Latest Growth Strategy News

Yojee Limited reports a robust cash reserve and significant progress in its MOSAIC platform beta testing, alongside new customer contracts and strategic leadership hires, setting the stage for its 2026 commercial rollout.

GreenX Metals has raised A$13.6 million through a share placement to fund exploration at its Tannenberg Copper Project in Germany and Eleonore North Gold and Antimony Project in Greenland, reinforcing its balance sheet for 2026.

CGN Resources has expanded its footprint in Western Australia's prolific Leonora Gold Province by acquiring the Desdemona Project from Patronus Resources, creating one of the largest consolidated landholdings in the region.

American Rare Earths has successfully produced Mixed Rare Earths Oxide from its Halleck Creek ore, marking a key technical milestone. The company also updated its resource estimate and strengthened leadership as it advances towards becoming a major U.S. rare earths supplier.

SSH Group Ltd reported a robust December quarter with a 31% revenue increase, driven by strong mining and hire division performances. The company advanced its Wagtail Gold Deposit development and secured a $2.53 million strategic placement with Xinhai Mining Services, positioning itself for growth in 2026.

LTR Pharma has marked a key milestone with over 1,000 SPONTAN prescriptions under Australia’s Special Access Scheme and is advancing clinical trials and US market preparations for its erectile dysfunction treatments.

Tetratherix Limited (ASX, TTX) reports significant progress in clinical trials, strategic partnerships, and manufacturing capacity, positioning itself for near-term commercialisation and sustained innovation.

Following its December 2025 ASX debut and a successful IPO, Saluda Medical reports robust global revenue growth and expands its US sales force, prompting an upward revision of its FY26 revenue guidance.

Brightstar Resources has reported significant early-stage gold intercepts from its Sandstone Hub aircore drilling program, highlighting promising targets for upcoming drilling campaigns.

Firebrick Pharma has commenced commercial manufacturing and export of its new Nasodine Throat Spray, marking a significant step in its international expansion. The company also reported a 15% increase in cash sales and reduced operating costs, signalling improving financial health.

Grand Gulf Energy has progressed its Petroleum Exploration Licence application offshore Namibia and continued development discussions for its Red Helium Project, maintaining a disciplined capital approach during the December 2025 quarter.

Talga Group has successfully raised A$7.3 million through an oversubscribed Share Purchase Plan, surpassing its A$5 million target to fund a significant ramp-up in graphite anode production and support strategic growth initiatives.